Keywords: abbott, posts, sales, growth, 3rd-qtr, led, arthritis

Abbott posts 10.2% sales growth for 3rd-qtr 2004, led by arthritis drug Humira

Article | 25 October 2004

Print This

US drug giant Abbott Laboratories comfortably met consensus targets for the third quarter of 2004, posting sales growth of 10.2%, driven, in ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in